Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-20-003189
Filing Date
2020-03-24
Accepted
2020-03-24 17:16:26
Documents
78
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tnxp-10k_123119.htm 10-K 2268140
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED ex4-06.htm EX-4.06 19537
3 RESEARCH COLLABORATION AGREEMENT ex10-18.htm EX-10.18 88144
4 SUBSIDIARIES ex21-01.htm EX-21.01 7341
5 CONSENT ex23-01.htm EX-23.01 6024
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10565
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 9881
8 CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS ex32-01.htm EX-32.01 6285
15 GRAPHIC ex1018001.jpg GRAPHIC 4209
16 GRAPHIC ex1018002.jpg GRAPHIC 9408
17 GRAPHIC ex1018003.jpg GRAPHIC 2207
  Complete submission text file 0001387131-20-003189.txt   6218710

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT tnxp-20191231.xml EX-101.INS 748466
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20191231.xsd EX-101.SCH 58649
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20191231_cal.xml EX-101.CAL 57516
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20191231_def.xml EX-101.DEF 235950
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20191231_lab.xml EX-101.LAB 428566
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20191231_pre.xml EX-101.PRE 326434
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 20739225
SIC: 2834 Pharmaceutical Preparations